Patrick E. Burnett's most recent trade in Arcutis Biotherapeutics Inc was a trade of 2,438 Common Stock done at an average price of $15.6 . Disclosure was reported to the exchange on Aug. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.57 per share. | 19 Aug 2025 | 2,438 | 104,811 (0%) | 0% | 15.6 | 37,969 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 16.16 per share. | 19 Aug 2025 | 1,750 | 107,249 (0%) | 0% | 16.2 | 28,281 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 14.03 per share. | 08 Aug 2025 | 3,847 | 108,999 (0%) | 0% | 14.0 | 53,988 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 14.33 per share. | 04 Aug 2025 | 2,622 | 112,846 (0%) | 0% | 14.3 | 37,564 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 23,000 | 138,468 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 23,000 | 178,250 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.05 per share. | 10 Jul 2025 | 23,000 | 115,468 (0%) | 0% | 15.0 | 346,047 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 5,750 | 172,500 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.07 per share. | 10 Jul 2025 | 5,750 | 115,468 (0%) | 0% | 15.1 | 86,654 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2025 | 5,750 | 121,218 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 13.59 per share. | 08 May 2025 | 3,871 | 115,468 (0%) | 0% | 13.6 | 52,623 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick E. Burnett | See Remarks | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 02 May 2025 | 2,597 | 119,339 (0%) | 0% | 15.2 | 39,442 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 14.97 per share. | 13 Mar 2025 | 44,153 | 121,936 (0%) | 0% | 15.0 | 660,772 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 12,242 | 201,250 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 15.04 per share. | 13 Mar 2025 | 12,242 | 121,936 (0%) | 0% | 15.0 | 184,107 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 12,242 | 134,178 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,008 | 213,492 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 15.10 per share. | 13 Mar 2025 | 5,008 | 121,936 (0%) | 0% | 15.1 | 75,631 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2025 | 5,008 | 126,944 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 43,000 | 43,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 38,000 | 152,862 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 17,000 | 169,862 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 28 Feb 2025 | 2,819 | 167,043 (0%) | 0% | 13.0 | 36,735 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 28 Feb 2025 | 954 | 166,089 (0%) | 0% | 13.3 | 12,673 | Common Stock |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2025 | 12,116 | 114,862 (0%) | 0% | 12.7 | 153,873 | Common Stock |